Yes, there is still opportunity for growth here. If people who are honestly throwing money into the sector to see where it goes three to five years out, they can only look to the fact that Green Cures is one year old in a (still) fairly latent sector.

We're through with the Calkin hype, they mishit badly with Jones, who was a non-factor and now it goes one of two ways. Months of silence like many other companies, or as philip stated, two to four weeks out, a new CEO who is dedicated to the company.

Either way, I wouldn't be surprised to watch it drop significantly further until something of significance resets the wheels in motion. If not, then it'll sit in the trips and Cruz will be taking the worst haircut out of all of us.

My summary shouldn't bother anyone who invested in this for the long-term growth of MMJ/MJ and the sector as we've barely scratched the surface.There's still a chance.